Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic rosuvastatin 20 mg vs Crestor 20 mg under fasting in healthy Thai volunteers
TCTR20230210002Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin in hypercholesterolemia (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20230210002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230210002.